Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Share-based Compensation (2016 - 2017)

Historic Share-based Compensation for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to $209626.0.

  • Bone Biologics' Share-based Compensation fell 8260.23% to $209626.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $1.6 million, marking a year-over-year decrease of 6102.49%. This contributed to the annual value of $207035.0 for FY2021, which is N/A changed from last year.
  • Bone Biologics' Share-based Compensation amounted to $209626.0 in Q4 2017, which was down 8260.23% from $367157.0 recorded in Q3 2017.
  • Over the past 5 years, Bone Biologics' Share-based Compensation peaked at $1.2 million during Q4 2016, and registered a low of $209626.0 during Q4 2017.